[Federal Register Volume 71, Number 57 (Friday, March 24, 2006)]
[Notices]
[Page 14959]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-4286]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes; Renewal
Notice
AGENCY: U. S. Nuclear Regulatory Commission.
ACTION: This notice is to announce the renewal of the Advisory
Committee on the Medical Uses of Isotopes (ACMUI) for a period of two
years.
-----------------------------------------------------------------------
SUPPLEMENTARY INFORMATION: The U.S. Nuclear Regulatory Commission (NRC)
has determined that the renewal of the charter for the Advisory
Committee on the Medical Uses of Isotopes for the two year period
commencing on March 17, 2006 is in the public interest, in connection
with duties imposed on the Commission by law. This action is being
taken in accordance with the Federal Advisory Committee Act, after
consultation with the Committee Management Secretariat, General
Services Administration.
The purpose of the ACMUI is to provide advice to NRC on policy and
technical issues that arise in regulating the medical use of byproduct
material for diagnosis and therapy. Responsibilities include providing
guidance and comments on current and proposed NRC regulations and
regulatory guidance concerning medical use; evaluating certain non-
routine uses of byproduct material for medical use; and evaluating
training and experience of proposed authorized users. The members are
involved in preliminary discussions of major issues in determining the
need for changes in NRC policy and regulation to ensure the continued
safe use of byproduct material. Each member provides technical
assistance in his/her specific area(s) of expertise, particularly with
respect to emerging technologies. Members also provide guidance as to
NRC's role in relation to the responsibilities of other Federal
agencies as well as of various professional organizations and boards.
Members of this Committee have demonstrated professional
qualifications and expertise in both scientific and non-scientific
disciplines including nuclear medicine; nuclear cardiology; radiation
therapy; medical physics; nuclear pharmacy; State medical regulation;
patient's rights and care; health care administration; and Food and
Drug Administration regulation.
FOR FURTHER INFORMATION PLEASE CONTACT: Mohammad S. Saba, Office of
Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory
Commission, Washington, DC 20555; Telephone (301) 415-7608; e-mail
[email protected].
Dated: March 17, 2006.
Andrew L. Bates,
Federal Advisory Committee, Management Officer.
[FR Doc. E6-4286 Filed 3-23-06; 8:45 am]
BILLING CODE 7590-01-P